| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| BIOEXTRAX Aktie jetzt für 0€ handeln | |||||
| 13.10. | Listing of units rights and paid subscription units of Bioextrax AB | 437 | GlobeNewswire | With effect from October 14, 2026, the units rights in Bioextrax AB will be traded on First North Growth Market. Trading will continue up until and including October 23, 2026.
... ► Artikel lesen | |
| 08.10. | XFRA CAPITAL ADJUSTMENT INFORMATION - 08.10.2026 | 354 | Xetra Newsboard | Das Instrument 0PD0 GB00BSB7BS06 PINEWOOD TECH.GR. LS 1,0 EQUITY wird cum Kapitalmassnahme gehandelt am 08.10.2026 und ex Kapitalmassnahme am 09.10.2026 The instrument 0PD0 GB00BSB7BS06 PINEWOOD TECH.GR.... ► Artikel lesen | |
| 20.08. | Bioextrax AB Q2 Sales Decline | 1 | RTTNews | ||
| 26.11.25 | Listing of subscription rights and paid subscription shares of Bioextrax AB | 463 | GlobeNewswire | With effect from November 27, 2025, the subscription rights in Bioextrax AB will be traded on First North Growth Market. Trading will continue up until and including December 08, 2025.
Instrument:
Subscription... ► Artikel lesen | |
| 24.11.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 24.11.2025 | 605 | Xetra Newsboard | Das Instrument WTGA IE000TB3YTV4 WSDMTR.GL AUTO.INNO.DLACC ETF wird cum Kapitalmassnahme gehandelt am 24.11.2025 und ex Kapitalmassnahme am 25.11.2025 The instrument WTGA IE000TB3YTV4 WSDMTR.GL AUTO.INNO.DLACC... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AMGEN | 394,45 | -1,36 % | Dividendenbekanntmachungen (20.11.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCO BRANDS CORPORATION US00081T1088 0,075 USD 0,0683 EUR AGNT INC US30212W1009 0,05 USD 0,0455 EUR AMGEN INC US0311621009 2... ► Artikel lesen | |
| VALNEVA | 2,409 | -0,33 % | Valneva im Check: Starke Shigella-Daten - reicht der Schwung? | ||
| EPIGENOMICS | 0,870 | 0,00 % | PTA-PVR: Epigenomics AG: Veröffentlichung nach § 40 Abs. 1 WpHG | DJ PTA-PVR: Epigenomics AG: Veröffentlichung nach § 40 Abs. 1 WpHG
Veröffentlichung gem. -- 40 Abs. 1 WpHG
Epigenomics AG: Veröffentlichung nach -- 40 Abs. 1 WpHG
Heidelberg (pta000/26.10.2026/15:00... ► Artikel lesen | |
| STRYKER | 284,70 | -0,28 % | Stryker: 178,92-Millionen-Verkauf - was steckt dahinter? | ||
| OCUGEN | 0,676 | +1,20 % | Ocugen nach Lizenzdeal mit Celairis: Diese Marke entscheidet jetzt | ||
| BIO-GATE | 2,000 | 0,00 % | Original-Research: Bio-Gate AG (von BankM AG): Kaufen | Original-Research: Bio-Gate AG - von BankM AG
10.11.2026 / 12:44 CET/CEST
Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group.
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| SAREPTA THERAPEUTICS | 12,940 | +0,31 % | Sarepta Therapeutics auf Guggenheim-Konferenz: Starker Cashflow finanziert breite Entwicklungspipeline | ||
| 10X GENOMICS | 50,99 | -2,52 % | 10X Genomics: ARK verkauft - was Anleger jetzt prüfen | ||
| USANA HEALTH SCIENCES | 11,800 | -0,84 % | USANA HEALTH SCIENCES INC - 10-Q/A, Quarterly Report | ||
| BIO-TECHNE | 65,18 | 0,00 % | Dividendenbekanntmachungen (13.11.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCENTURE PLC IE00B4BNMY34 1,71 USD EUR ALBEMARLE CORPORATION PREF A US0126532003 0,9062 USD 0,8197 EUR AMERANT BANCORP INC US0235761014 0... ► Artikel lesen | |
| VERACYTE | 23,180 | +1,53 % | Veracyte, Inc.: Six Studies to Highlight Veracyte's Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026 | Oral presentations include new Decipher treatment-selection evidence and an OPTIMA breast cancer health economic analysisSOUTH SAN FRANCISCO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Veracyte, Inc.... ► Artikel lesen | |
| INNATE PHARMA | 0,872 | 0,00 % | Innate Pharma SA: Innate Pharma Presents Initial Phase 1 Clinical Data for IPH4502 at ENA 2026 | Encouraging tolerability profile with stomatitis as the only dose-limiting toxicity; low overall hematologic toxicity, consistent with low circulating free-exatecan levels, supporting linker... ► Artikel lesen | |
| XENON PHARMACEUTICALS | 34,400 | +0,58 % | Xenon Pharmaceuticals Inc.: Xenon Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program | New Drug Application for azetukalner in focal seizures submitted to U.S. Food and Drug Administration; X-TOLE3 and X-ACKT continue to enroll focal seizure and PGTCS patients, respectively Enrollment... ► Artikel lesen | |
| NUCANA | 0,717 | -0,15 % | NuCana plc: NuCana Reports Third Quarter 2026 Financial Results and Provides Business Update | Development Programme for NUC-7738 Advances with Three Presentations Planned at ESMO Immuno-Oncology & Advanced Therapies Congress in December 2026
European Composition-of-Matter Patent Granted... ► Artikel lesen | |
| PROTARA THERAPEUTICS | 2,092 | -4,12 % | Protara Therapeutics Announces Third Quarter 2026 Financial Results and Provides a Business Update |